Lipoprotein(a) is associated with large artery atherosclerosis stroke aetiology and stroke recurrence among patients below the age of 60 years: results from the BIOSIGNAL study.

Publication

Lipoprotein(a) is associated with large artery atherosclerosis stroke aetiology and stroke recurrence among patients below the age of 60 years: results from the BIOSIGNAL study.

Journal Paper/Review - Jun 7, 2021

Arnold Markus, Schweizer Juliane, Nakas Christos T, Schütz Valerie, Westphal Laura Philine, Inauen Corinne, Pokorny Thomas, Luft Andreas R, Leichtle Alexander, Arnold Marcel, Bicvic Antonela, Fischer Urs, De Marchis Gian Marco, Bonati Leo H, Delignette-Muller Marie Laure, Kahles Timo, Nedeltchev Krassen, Cereda Carlo W, Kägi Georg, Bustamante Alejandro, Montaner Joan, Ntaios Georges, Foerch Christian, Spanaus Katharina, von Eckardstein Arnold, Katan Mira

Citation

Arnold M, Schweizer J, Nakas C, Schütz V, Westphal L, Inauen C, Pokorny T, Luft A, Leichtle A, Arnold M, Bicvic A, Fischer U, De Marchis G, Bonati L, Delignette-Muller M, Kahles T, Nedeltchev K, Cereda C, Kägi G, Bustamante A, Montaner J, Ntaios G, Foerch C, Spanaus K, von Eckardstein A, Katan M. Lipoprotein(a) is associated with large artery atherosclerosis stroke aetiology and stroke recurrence among patients below the age of 60 years: results from the BIOSIGNAL study. Eur Heart J 2021; 42:2186-2196.

Type

Journal Paper/Review (English)

Journal

Eur Heart J 2021; 42

Publication Date

Jun 7, 2021

Issn Electronic

1522-9645

Pages

2186-2196

Brief description/objective

Lipoprotein(a) [Lp(a)] is a recognized causal risk factor for atherosclerotic cardiovascular disease but its role for acute ischaemic stroke (AIS) is controversial. In this study, we evaluated the association of Lp(a) with large artery atherosclerosis (LAA) stroke and risk of recurrent cerebrovascular events in AIS patients.